PAP Devices Market (2025-2032)
The PAP Devices Market is projected to reach $6.97 billion by 2032, at a CAGR of 5.2% from 2025 to 2032.
- Published
- Jan 2025
- Pages
- 230
- Format
- PDF + Excel
- Report ID
- MR-851
- Base year
- 2024
- 2032 · FORECAST
- $6.97B
- 2032
- $6.97B
- CAGR 2025–2032
- 5.2%
2024 baseline · 2025–2032 forecast at 5.2% CAGR · hover a bar for the value
Key highlights
By Product: In 2025, the Continuous Positive Airway Pressure (CPAP) Devices Segment to Dominate the PAP Devices Market
By Application: the Obstructive Sleep Apnea (OSA) Segment to Dominate the PAP Devices Market
By End User: the Hospitals & Sleep Clinics Segment to Dominate the PAP Devices Market
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 230 |
| Format | |
| Forecast Period | 2025–2032 |
| Base Year | 2024 |
| CAGR (Value) | 5.2% |
| Market Size (Value) | USD 6.97 billion by 2032 |
| Segments Covered | By Product · Continuous Positive Airway Pressure (CPAP) Devices · Bilevel Positive Airway Pressure (BiPAP) Devices · Automatic Positive Airway Pressure (APAP) Devices · Accessories · Masks · Full Face Masks · Nasal Masks · Nasal Pillows/Cushion Masks · Headgear · Other Accessories · (Note: Other accessories include air filters, CPAP pillow, nasal pads, and power adapters & Batteries) · By Disease · Obstructive Sleep Apnea (OSA) · Respiratory Failure · Chronic Obstructive Pulmonary Disease (COPD) · Heart Failure · By End User · Hospitals and Sleep Clinics · Home Healthcare Settings |
| Countries Covered | North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, Sweden, Belgium, Denmark, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa) |
| Key Companies | ResMed Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Inspire Medical Systems, Inc. (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Rotech Healthcare Inc. (U.S.), Cardinal Health, Inc. (U.S.), Invacare Corporation (U.S.), Cleveland Medical Devices Inc. (U.S.), BMC Medical Co., Ltd. (China), Löwenstein Medical Technology GmbH + Co. KG. (Germany), SomnoMed, Inc. (Australia), Drive DeVilbiss Healthcare Ltd. (U.S.), and SunMed, LLC (U.S.) |
Report overview
Segments covered: type, disease. Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
The growth of this market is driven by the increasing prevalence of respiratory and sleeping disorders, the rising geriatric population suffering from respiratory disorders, the introduction of new sleep apnea devices, growing awareness about the adverse impacts of untreated sleep apnea, and favorable reimbursement policies for sleep apnea therapies and devices. However, PAP devices are expensive and not suitable for patients with certain conditions, which restrains the market’s growth.
Furthermore, technological advancements in positive airway pressure (PAP) devices and a rising focus on out-of-hospital healthcare are expected to offer significant market growth opportunities. However, the side effects of PAP devices and the low adherence rate for sleep apnea devices are challenging the market’s growth.
Market dynamics
5 factors across 3 forcesIncreasing Prevalence of Respiratory and Sleep Disorders
The prevalence of respiratory diseases is rising globally. Respiratory diseases are mainly caused due to smoking, infections, air pollution, dust, and chemicals. Some of the most common respiratory diseases are Chronic Obstructive Pulmonary Disease (COPD), asthma, lung cancer, pulmonary fibrosis, pneumonia, bronchitis, cystic fibrosis, and emphysema. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is among the most common causes of mortality worldwide. In 2020, the disorder accounted for approximately 3.23 million deaths, and low and middle-income countries (LMIC) accounted for 90% of COPD deaths among those below the age of 70.
Additionally, sleep disorders include sleep apnea and insomnia and are caused due to hormones, stress, anxiety, and digestive disorders. According to the National Institutes of Health (NIH), in 2021, 50 to 70 million people in the U.S. had chronic sleep disorders, with 40% of adults reportedly falling asleep during the day at least once a month. Thus, the increasing prevalence of respiratory diseases and sleep disorders has increased the adoption of APAP, CPAP, and BiPAP devices.
Increasing Geriatric Population Suffering from Respiratory Disorders
The aging population is on the rise due to increased life expectancy, improved healthcare, urbanization, and higher income levels, resulting in better survival rates. Aging brings about significant structural changes in the respiratory system, making elderly individuals more susceptible to respiratory diseases. Common symptoms include cough, asthma, COPD, sleep-disordered breathing, and dyspnea, necessitating a systematic approach to diagnosis.
However, elderly patients often face misdiagnosis and improper treatment for respiratory disorders. According to the United Nations, the global proportion of people aged 65 and older is projected to increase from 10% in 2022 to 16% in 2050. Significant annual increases in the elderly population are expected in Northern Africa, Western Asia, Sub-Saharan Africa, Oceania (excluding Australia and New Zealand), and Central and Southern Asia between 2022 and 2050.
Furthermore, according to data published by the World Health Organization (WHO) in 2022, by 2032, one in every six people globally will be 60 years or older, with the population aged 60 and above expected to grow from 1 billion in 2020 to 1.4 billion by 2032, and to 2.1 billion by 2050. This demographic shift will lead to a higher prevalence of respiratory disorders among the elderly, increasing the demand for PAP devices.
Table of contents
11 chapters · 113 sections · 230 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Product | Continuous Positive Airway Pressure (CPAP) Devices | — |
| By Application | Obstructive Sleep Apnea (OSA) | — |
| By End User | Hospitals & Sleep Clinics | — |
By Product
- The continuous positive airway pressure (CPAP) devices segment is expected to account for the largest share of 68.2% of the PAP devices market.
- The segment’s large market share is attributed to the availability of advanced noiseless CPAP machines with compact designs and advanced interfaces, technological advancements in PAP devices, and the rising availability & accessibility of new CPAP devices.
- Additionally, rising healthcare expenditures and increasing disposable incomes in emerging countries are driving the adoption of PAP devices.
By Application
- The obstructive sleep apnea (OSA) segment is expected to account for the largest share of the PAP devices market.
- The segment’s large market share is attributed to the introduction of products for treating obstructive sleep apnea.
- For instance, in August 2021, ResMed Inc. (U.S.) launched the AirSense 11 PAP Series of devices to manage and treat obstructive sleep apnea.
- Also, in September 2021, Sommetrics, Inc. (U.S.) ran clinical trials of the aerSleep II device developed for the treatment of obstructive sleep apnea.
By End User
- The hospitals & sleep clinics segment is expected to account for the largest share of 60.9% of the PAP devices market.
- The large market share of this segment is attributed to the rising prevalence of sleep apnea.
- According to the National Institutes of Health (NIH), in 2020, 936 million adults aged 30–69 suffered from mild to severe obstructive sleep apnea (OSA), and 425 million adults aged 30–69 suffered from moderate to severe obstructive sleep apnea globally.
Geographic analysis
North America
Largest shareIn 2025, North America is expected to account for the largest share of 41.5% of the PAP devices market, followed by Europe and Asia-Pacific. North America’s significant market share can be attributed to the growing awareness about the adverse impacts of untreated sleep apnea, increasing prevalence of respiratory and sleep disorders, and the presence of major PAP devices companies such as ResMed Inc. (U.S.), Rotech Healthcare Inc. (U.S.), and Cardinal Health, Inc. (U.S.). By Geography: In 2025, North America to Dominate the PAP Devices Market
Asia-Pacific
Fastest growthHowever, the market in Asia-Pacific is projected to register the highest growth rate of 5.7% during the forecast period. The growth of this regional market can be attributed to the increasing government spending on healthcare in countries such as China, India, Singapore, and South Korea, technological advancements in PAP devices, and increasing government initiatives to promote awareness. Furthermore, government initiatives supporting the development of healthcare facilities and increasing awareness about sleep disorders and respiratory disorders contribute to the growth of this regional market.
Competitive landscape
- March 2025
ResMed Inc. (U.S.) launched the AirFit F40 ultra-compact, full-face mask for sleep apnea.
- February 2025
ResMed Inc. (U.S.) launched the AirCurve 11 device, a new bi-level sleep apnea device, as a CPAP alternative to treat patients with sleep apnea.
- August 2021
ResMed Inc. (U.S.) launched AirSense, a next-generation positive airway pressure (PAP) device to provide specific guidance to PAP users and assist them ease into therapy with ease of nightly use for treating obstructive sleep apnea.
- ResMed Inc. (U.S.)
- Koninklijke Philips N.V. · Netherlands
- Inspire Medical Systems, Inc. (U.S.)
- Fisher & Paykel Healthcare Corporation Limited · New Zealand
- Medtronic plc · Ireland
- Rotech Healthcare Inc. (U.S.)
- Cardinal Health, Inc. (U.S.)
- Invacare Corporation (U.S.)
- Cleveland Medical Devices Inc. (U.S.)
- BMC Medical Co., Ltd. · China
- Löwenstein Medical Technology GmbH + Co. KG · Germany
- SomnoMed, Inc. · Australia
Frequently asked questions
This study offers a detailed assessment of the PAP devices market and provides market sizes & forecasts based on product, disease, and end user. This report also involves the value analysis of various segments and subsegments of the PAP devices market at the regional and country levels.
Cite this report
Meticulous Research. (2025). PAP Devices Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MR-851). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/reports/pap-devices-market-5534